Cargando…
Global identification of circular RNAs in imatinib (IM) resistance of chronic myeloid leukemia (CML) by modulating signaling pathways of circ_0080145/miR-203/ABL1 and circ 0051886/miR-637/ABL1
Imatinib (IM), targeting of BCR-ABL1 tyrosine kinase, is currently one of the first-line choices in the treatment of chronic myeloid leukemia (CML). This study aims to explore the molecular mechanisms underlying IM resistance in CML treatment. 108 CML patients were recruited and grouped according to...
Autores principales: | Lu, Yao-hua, Huang, Zhong-yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591874/ https://www.ncbi.nlm.nih.gov/pubmed/34781898 http://dx.doi.org/10.1186/s10020-021-00395-z |
Ejemplares similares
-
Inhibition of BCR/ABL Protein Expression by miR-203 Sensitizes for Imatinib Mesylate
por: Li, Yajuan, et al.
Publicado: (2013) -
circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637
por: Zhang, Yanli, et al.
Publicado: (2019) -
CircLDLR Promotes Papillary Thyroid Carcinoma Tumorigenicity by Regulating miR-637/LMO4 Axis
por: Jiang, Yuan-ming, et al.
Publicado: (2021) -
Circ_0081054 facilitates melanoma development via sponging miR‐637 and regulating RAB9A
por: Li, Xiaoqing, et al.
Publicado: (2023) -
CircHIPK3 Promotes the Tumorigenesis and Development of Gastric Cancer Through miR-637/AKT1 Pathway
por: Yang, Dejun, et al.
Publicado: (2021)